Initial Safety Assessment of SNS-595 for the Treatment of Solid Tumors.

NCT00091585 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sunesis Pharmaceuticals